First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney.OPTIMAL-e will evaluate TLX597-Tx in earlier…